Determination of HIV viral load by real-time PCR

This tender concerns the determination of HIV viral load using real-time Polymerase Chain Reaction (PCR) technology. The service aims to accurately quantify the amount of HIV genetic material present in a patient's blood sample. Real-time PCR is a highly sensitive and specific molecular diagnostic technique that allows for the direct measurement of viral RNA or DNA. This diagnostic capability is crucial for monitoring the effectiveness of antiretroviral therapy (ART) in individuals living with HIV. By measuring viral load, healthcare providers can assess whether the treatment is successfully suppressing viral replication and preventing disease progression. Furthermore, viral load measurements are essential for guiding treatment decisions, identifying potential drug resistance, and assessing the risk of HIV transmission. The tender likely seeks to procure services or reagents for performing these critical diagnostic tests. The specific requirements may include the type of real-time PCR platform, the sensitivity and specificity of the assay, turnaround times for results, and quality control measures. This service is fundamental to comprehensive HIV/AIDS management programs, ensuring optimal patient outcomes and public health efforts to control the epidemic.

This is a supplies contract in the health and medical services sector, with a focus on Laboratory and Infectious Diseases. Located in Spain, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 2.0 million.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.